Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20307660rdf:typepubmed:Citationlld:pubmed
pubmed-article:20307660lifeskim:mentionsumls-concept:C0439660lld:lifeskim
pubmed-article:20307660lifeskim:mentionsumls-concept:C0009333lld:lifeskim
pubmed-article:20307660lifeskim:mentionsumls-concept:C0009326lld:lifeskim
pubmed-article:20307660lifeskim:mentionsumls-concept:C0151650lld:lifeskim
pubmed-article:20307660lifeskim:mentionsumls-concept:C1333206lld:lifeskim
pubmed-article:20307660lifeskim:mentionsumls-concept:C0205421lld:lifeskim
pubmed-article:20307660lifeskim:mentionsumls-concept:C1517945lld:lifeskim
pubmed-article:20307660pubmed:issue5lld:pubmed
pubmed-article:20307660pubmed:dateCreated2010-7-12lld:pubmed
pubmed-article:20307660pubmed:abstractTextAlport syndrome is a hereditary type IV collagen disease leading to progressive renal fibrosis, hearing loss and ocular changes. End stage renal failure usually develops during adolescence. COL4A3-/- mice serve as an animal model for progressive renal scarring in Alport syndrome. The present study evaluates the role of Discoidin Domain Receptor 1 (DDR1) in cell-matrix interaction involved in pathogenesis of Alport syndrome including renal inflammation and fibrosis. DDR1/COL4A3 Double-knockouts were compared to COL4A3-/- mice with 50% or 100% expression of DDR1, wildtype controls and to DDR1-/- COL4A3+/+ controls for over 6years. Double-knockouts lived 47% longer, mice with 50% DDR1 lived 29% longer and showed improved renal function (reduction in proteinuria and blood urea nitrogen) compared to animals with 100% DDR1 expression. Loss of DDR1 reduced proinflammatory, profibrotic cells via signaling of TGFbeta, CTGF, NFkappaB and IL-6 and decreased deposition of extracellular matrix. Immunogold-staining and in-situ hybridisation identified podocytes as major players in DDR1-mediated fibrosis and inflammation within the kidney. In summary, glomerular epithelial cells (podocytes) express DDR1. Loss of DDR1-expression in the kidney delayed renal fibrosis and inflammation in hereditary type IV collagen disease. This supports our hypothesis that podocyte-matrix interaction via collagen receptors plays an important part in progression of renal fibrosis in Alport disease. The blockade of collagen-receptor DDR1 might serve as an important new therapeutic concept in progressive fibrotic and inflammatory diseases in the future.lld:pubmed
pubmed-article:20307660pubmed:languageenglld:pubmed
pubmed-article:20307660pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307660pubmed:citationSubsetIMlld:pubmed
pubmed-article:20307660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307660pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307660pubmed:statusMEDLINElld:pubmed
pubmed-article:20307660pubmed:monthJunlld:pubmed
pubmed-article:20307660pubmed:issn1569-1802lld:pubmed
pubmed-article:20307660pubmed:authorpubmed-author:KretzlerMatth...lld:pubmed
pubmed-article:20307660pubmed:authorpubmed-author:SegererStepha...lld:pubmed
pubmed-article:20307660pubmed:authorpubmed-author:MiosgeNicolai...lld:pubmed
pubmed-article:20307660pubmed:authorpubmed-author:VogelWolfgang...lld:pubmed
pubmed-article:20307660pubmed:authorpubmed-author:GrossOliverOlld:pubmed
pubmed-article:20307660pubmed:authorpubmed-author:WeberManfredMlld:pubmed
pubmed-article:20307660pubmed:authorpubmed-author:KangHee...lld:pubmed
pubmed-article:20307660pubmed:authorpubmed-author:GirgertRainer...lld:pubmed
pubmed-article:20307660pubmed:authorpubmed-author:BeirowskiBogd...lld:pubmed
pubmed-article:20307660pubmed:authorpubmed-author:MüllerGerhard...lld:pubmed
pubmed-article:20307660pubmed:authorpubmed-author:BusseAnn-Chri...lld:pubmed
pubmed-article:20307660pubmed:authorpubmed-author:KruegelJennyJlld:pubmed
pubmed-article:20307660pubmed:copyrightInfoCopyright (c) 2010 Elsevier B.V. All rights reserved.lld:pubmed
pubmed-article:20307660pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20307660pubmed:volume29lld:pubmed
pubmed-article:20307660pubmed:ownerNLMlld:pubmed
pubmed-article:20307660pubmed:authorsCompleteYlld:pubmed
pubmed-article:20307660pubmed:pagination346-56lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:meshHeadingpubmed-meshheading:20307660...lld:pubmed
pubmed-article:20307660pubmed:year2010lld:pubmed
pubmed-article:20307660pubmed:articleTitleLoss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease.lld:pubmed
pubmed-article:20307660pubmed:affiliationDepartment of Nephrology & Rheumatology, University Medicine Goettingen Robert-Koch Strasse 40, Goettingen, Germany. gross.oliver@med.uni-goettingen.delld:pubmed
pubmed-article:20307660pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20307660pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:12305entrezgene:pubmedpubmed-article:20307660lld:entrezgene
entrez-gene:12828entrezgene:pubmedpubmed-article:20307660lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20307660lld:entrezgene